BMJ:外科医生具体结果公开报告制度对结肠癌患者治疗方案及预后的影响

2018-05-04 zhangfan MedSci原创

研究认为外科医生具体结果公开报告制度对结肠癌手术患者治疗方法无显著影响,但患者术后死亡率呈下降趋势

近日研究人员考察了外科医生具体结果公开报告制度对结肠癌患者手术策略、临床数据以及患者预后的影响。

研究在英国开展,111431名结肠癌患者参与研究,主要考察患者择期结直肠癌手术后90天死亡率。研究主要终点为结直肠癌选择性大切除术患者的比例、根据病人和肿瘤特点预测90天的死亡率以及调整后患者90天死亡率。

研究发现,制度执行前后患者结直肠癌大切除术实施率无显著变化(制度实施前39792/62854 [63.3%] vs实施后 30706/48577 [63.2%]; P=0.8)。制度执行前后患者结直肠癌大切除术选择或排定率无显著变化(制度实施前33638/39792 [84.5%] vs 25905/30706 [84.4%]; P=0.5)。患者90天预期死亡率无显著变化(2.7 vs 2.7%)而90天实际死亡率略微下降(2.8 vs 2.1%)。

研究认为外科医生具体结果公开报告制度对结肠癌手术患者治疗方法无显著影响,但患者术后死亡率呈下降趋势。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1848511, encodeId=2f961848511fd, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Mar 30 08:06:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905054, encodeId=4528190505416, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64648, encryptionId=21f66464823, topicName=治疗方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee4187, createdName=zhangjiqing, createdTime=Sun Apr 14 08:06:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312457, encodeId=1b2331245e85, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun May 06 07:29:17 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1420716, encodeId=4aac1420e169d, content=<a href='/topic/show?id=d2514292149' target=_blank style='color:#2F92EE;'>#外科医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42921, encryptionId=d2514292149, topicName=外科医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a73606138, createdName=ysjykql, createdTime=Sun May 06 02:06:00 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312310, encodeId=79143123109f, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sat May 05 21:39:39 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311929, encodeId=c6ed31192900, content=研究在英国开展.111431名结肠癌患者参与研究.主要考察患者择期结直肠癌手术后90天死亡率.研究主要终点为结直肠癌选择性大切除术患者的比例.根据病人和肿瘤特点预测90天的死亡率以及调整后患者90天死亡率., beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Fri May 04 13:04:13 CST 2018, time=2018-05-04, status=1, ipAttribution=)]
    2019-03-30 gaoxiaoe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1848511, encodeId=2f961848511fd, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Mar 30 08:06:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905054, encodeId=4528190505416, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64648, encryptionId=21f66464823, topicName=治疗方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee4187, createdName=zhangjiqing, createdTime=Sun Apr 14 08:06:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312457, encodeId=1b2331245e85, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun May 06 07:29:17 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1420716, encodeId=4aac1420e169d, content=<a href='/topic/show?id=d2514292149' target=_blank style='color:#2F92EE;'>#外科医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42921, encryptionId=d2514292149, topicName=外科医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a73606138, createdName=ysjykql, createdTime=Sun May 06 02:06:00 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312310, encodeId=79143123109f, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sat May 05 21:39:39 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311929, encodeId=c6ed31192900, content=研究在英国开展.111431名结肠癌患者参与研究.主要考察患者择期结直肠癌手术后90天死亡率.研究主要终点为结直肠癌选择性大切除术患者的比例.根据病人和肿瘤特点预测90天的死亡率以及调整后患者90天死亡率., beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Fri May 04 13:04:13 CST 2018, time=2018-05-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1848511, encodeId=2f961848511fd, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Mar 30 08:06:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905054, encodeId=4528190505416, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64648, encryptionId=21f66464823, topicName=治疗方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee4187, createdName=zhangjiqing, createdTime=Sun Apr 14 08:06:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312457, encodeId=1b2331245e85, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun May 06 07:29:17 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1420716, encodeId=4aac1420e169d, content=<a href='/topic/show?id=d2514292149' target=_blank style='color:#2F92EE;'>#外科医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42921, encryptionId=d2514292149, topicName=外科医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a73606138, createdName=ysjykql, createdTime=Sun May 06 02:06:00 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312310, encodeId=79143123109f, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sat May 05 21:39:39 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311929, encodeId=c6ed31192900, content=研究在英国开展.111431名结肠癌患者参与研究.主要考察患者择期结直肠癌手术后90天死亡率.研究主要终点为结直肠癌选择性大切除术患者的比例.根据病人和肿瘤特点预测90天的死亡率以及调整后患者90天死亡率., beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Fri May 04 13:04:13 CST 2018, time=2018-05-04, status=1, ipAttribution=)]
    2018-05-06 1209e435m98(暂无昵称)

    学习了.谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1848511, encodeId=2f961848511fd, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Mar 30 08:06:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905054, encodeId=4528190505416, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64648, encryptionId=21f66464823, topicName=治疗方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee4187, createdName=zhangjiqing, createdTime=Sun Apr 14 08:06:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312457, encodeId=1b2331245e85, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun May 06 07:29:17 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1420716, encodeId=4aac1420e169d, content=<a href='/topic/show?id=d2514292149' target=_blank style='color:#2F92EE;'>#外科医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42921, encryptionId=d2514292149, topicName=外科医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a73606138, createdName=ysjykql, createdTime=Sun May 06 02:06:00 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312310, encodeId=79143123109f, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sat May 05 21:39:39 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311929, encodeId=c6ed31192900, content=研究在英国开展.111431名结肠癌患者参与研究.主要考察患者择期结直肠癌手术后90天死亡率.研究主要终点为结直肠癌选择性大切除术患者的比例.根据病人和肿瘤特点预测90天的死亡率以及调整后患者90天死亡率., beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Fri May 04 13:04:13 CST 2018, time=2018-05-04, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1848511, encodeId=2f961848511fd, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Mar 30 08:06:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905054, encodeId=4528190505416, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64648, encryptionId=21f66464823, topicName=治疗方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee4187, createdName=zhangjiqing, createdTime=Sun Apr 14 08:06:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312457, encodeId=1b2331245e85, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun May 06 07:29:17 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1420716, encodeId=4aac1420e169d, content=<a href='/topic/show?id=d2514292149' target=_blank style='color:#2F92EE;'>#外科医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42921, encryptionId=d2514292149, topicName=外科医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a73606138, createdName=ysjykql, createdTime=Sun May 06 02:06:00 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312310, encodeId=79143123109f, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sat May 05 21:39:39 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311929, encodeId=c6ed31192900, content=研究在英国开展.111431名结肠癌患者参与研究.主要考察患者择期结直肠癌手术后90天死亡率.研究主要终点为结直肠癌选择性大切除术患者的比例.根据病人和肿瘤特点预测90天的死亡率以及调整后患者90天死亡率., beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Fri May 04 13:04:13 CST 2018, time=2018-05-04, status=1, ipAttribution=)]
    2018-05-05 天地飞扬

    了解一下.谢谢分享!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1848511, encodeId=2f961848511fd, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Sat Mar 30 08:06:00 CST 2019, time=2019-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905054, encodeId=4528190505416, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64648, encryptionId=21f66464823, topicName=治疗方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee4187, createdName=zhangjiqing, createdTime=Sun Apr 14 08:06:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312457, encodeId=1b2331245e85, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun May 06 07:29:17 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1420716, encodeId=4aac1420e169d, content=<a href='/topic/show?id=d2514292149' target=_blank style='color:#2F92EE;'>#外科医生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42921, encryptionId=d2514292149, topicName=外科医生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=40a73606138, createdName=ysjykql, createdTime=Sun May 06 02:06:00 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312310, encodeId=79143123109f, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Sat May 05 21:39:39 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311929, encodeId=c6ed31192900, content=研究在英国开展.111431名结肠癌患者参与研究.主要考察患者择期结直肠癌手术后90天死亡率.研究主要终点为结直肠癌选择性大切除术患者的比例.根据病人和肿瘤特点预测90天的死亡率以及调整后患者90天死亡率., beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Fri May 04 13:04:13 CST 2018, time=2018-05-04, status=1, ipAttribution=)]
    2018-05-04 有备才能无患

    研究在英国开展.111431名结肠癌患者参与研究.主要考察患者择期结直肠癌手术后90天死亡率.研究主要终点为结直肠癌选择性大切除术患者的比例.根据病人和肿瘤特点预测90天的死亡率以及调整后患者90天死亡率.

    0

相关资讯

JAMA Oncology:长达7年随访表明,遵守ACS营养和运动指南,能使中期肠癌患者术后5年生存率提高9%

近期发表在《美国医学会杂志-肿瘤学》(JAMA Oncology)上的一项临床研究结果显示显示:如果严格遵循美国癌症协会制定的营养和运动指南,诊断时处于病情中期的结肠癌患者(III期),术后5年生存率可以从76%提高到85%,死亡风险相对下降了42%!

Gastroenterology:特异性微生物菌血症导致后继结直肠癌风险增加

研究发现,以脆弱芽孢杆菌以及溶菌为代表的菌血症患者其后继结肠癌风险增加,这类细菌因肠道功能失调和屏障功能紊乱进入血液。该结果证实了肠道微生物群与结直肠癌发生的相关性

PNAS:研究发现肥胖与结肠癌关联的新分子机制

肥胖已成为全球性的健康问题,大量证据显示肥胖人群有更高罹患结肠癌的风险,而结肠组织炎症是结肠癌的主要风险因素。30日发表在美国《国家科学院学报》杂志上的一项研究揭示了肥胖增加结肠组织炎症的新分子机制。

NEJM:结肠切除征-病例报道

该患者结肠切除征是由于结肠癌引起的机械狭窄所致。当炎症引起脾曲线痉挛或变窄时,结肠切除征象通常与急性胰腺炎相关。

Gastroenterology:肠道锯齿状息肉和传统腺瘤风险因素研究

研究发现锯齿状息肉和传统腺瘤存在共同的致病风险因素,该研究为结直肠肿瘤的病因异质性提供了依据

Cancer Res:揭示RIPK1/MCU对结肠癌发生的调节机理

近期,北京大学分子医学研究所张秀琴课题组和中国医学科学院肿瘤医院蔡建强课题组在国际知名学术期刊《癌症研究》(Cancer Research)上在线发表题为“RIPK1 binds MCU to mediate induction of mitochondrial Ca2+ uptake and promote colorectal oncogenesis”的文章,揭示了结肠癌发展的新机制。